InVivo Therapeutics adds UVA Health System as INSPIRE study site: 4 takeaways

InVivo Therapeutics added University of Virginia Health System in Charlottesville as a clinical site for the INSPIRE study.

Advertisement

Here are four takeaways:

 

1. The INSPIRE study examines the potential benefit of InVivo’s Neuro-Spinal Scaffold.

 

2. The Neuro-Spinal Scaffold is an investigational device, and it has received a Humanitarian Use Device designation.

 

3. The implantable scaffold is intended to reduce post-traumatic cavity formation and allow neural regeneration after acute spinal cord injury.

 

4. There are now 19 clinical sites participating in the clinical study.

 

More articles on devices:
NuVasive to show Integrated Global Alignment platform at BritSpine: 3 takeaways
Analysts rate Exactech shares — 5 facts
Beyond the device: How DePuy Synthes is innovating in orthopedic & spine technology

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in Spinal Tech

  • From new technology acquisitions to regulatory clearances to leadership changes, here are 20 developments and updates from the biggest players…

  • VB Spine has made big pushes into the spine medtech space so far in 2026, including global expansions. Six headlines…

Advertisement

Comments are closed.